Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Beta Bionics priced an underwritten public offering of 7,652,175 common shares at $17.25 per share, plus pre-funded warrants for 1,043,484 shares, for expected gross proceeds of $150.0 million before fees. Net proceeds are earmarked for general corporate purposes, including commercialization of Mint, manufacturing expansion, R&D and clinical development, product enhancements, potential strategic opportunities, and working capital. J.P.
Key figures
- Deal Value Usd
- 150000000
- Offering Price
- 17.25
- Shares Offered
- 7652175
- Expected close
- September 17, 2026
- Over allotment shares
- 1304348
- Prefunded warrant price
- 17.2499
- Prefunded warrant shares
- 1043484
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.